AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitacip M 50/1000 Tablet PR

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitacip M 50/1000 Tablet PR

Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with Sitacip M 50/1000 Tablet PR, a dual-action medication. This formulation helps mitigate serious diabetic complications like vision impairment and renal damage, potentially lowering heart attack and stroke risks. Sitacip M 50/1000 Tablet PR can be used as monotherapy or in conjunction with other antidiabetic treatments. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glycemic control, and existing medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation requires physician approval. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; patients should be aware of its symptoms and management. This medication isn't suitable for all individuals. Prior to use, disclose any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel. Inform your doctor of all other medications to avoid potential interactions. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Sitacip M 50/1000 Tablet PR

Managing type 2 diabetes

Major Benefits of Sitacip M 50/1000 Tablet PR:

Follow your doctor's instructions or refer to the product label for proper administration. Consume Sitacip M 50/1000 Tablet PR with a meal.

Common Side effects of Sitacip M 50/1000 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitacip M 50/1000 Tablet PR:

Follow your doctor's instructions or consult the product label for guidance. Take Sitacip M 50/1000 Tablet PR with a meal.

How Sitacip M 50/1000 Tablet PR works:

Sitacip M 50/1000 Tablet PR combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sitacip M 50/1000 Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitacip M 50/1000 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitacip M 50/1000 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Sitacip M 50/1000 Tablet PR with care, potentially requiring dosage modification. Consult your physician for guidance. Sitacip M 50/1000 Tablet PR is contraindicated in patients exhibiting severe kidney dysfunction. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Sitacip M 50/1000 Tablet PR due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitacip M 50/1000 Tablet PR :

Should you forget a dose of Sitacip M 50/1000 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Sitacip M 50/1000 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitacip M 50/1000 Tablet PR

Sitacip M 50/1000 Tablet PR combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitacip M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitacip M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitacip M 50/1000 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitacip M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitacip M 50/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitacip M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitacip M 50/1000 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitacip M 50/1000 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitacip M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), and urinary problems, potentially affecting mental status. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacip M 50/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitacip M 50/1000 Tablet PR may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitacip M 50/1000 Tablet PR is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitacip M 50/1000 Tablet PR is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is a reason to avoid this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitacip M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacip M 50/1000 Tablet ...
113
MRP 131
13% off